TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
Teclison Ltd.
Teclison Ltd.
Kivu Bioscience Inc.
Incyte Corporation
BioNTech SE
Genentech, Inc.
AstraZeneca
Boehringer Ingelheim
AbbVie
MOMA Therapeutics
Astellas Pharma Inc
Exero Medical Ltd.
Novartis
Kura Oncology, Inc.
Boehringer Ingelheim
Hoffmann-La Roche
Pfizer
Takeda
Janssen Research & Development, LLC
7 Hills Pharma, LLC
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Bristol-Myers Squibb
GI Windows, Inc.
AbbVie
AstraZeneca
OncoC4, Inc.
Parabilis Medicines, Inc.
Jazz Pharmaceuticals
Kahr Medical
Harbinger Health
Genmab
Revolution Medicines, Inc.
Novartis
Bayer
AstraZeneca
Pfizer
Seagen Inc.
Pfizer
Seagen Inc.
Seagen Inc.
Seagen Inc.
Vividion Therapeutics, Inc.
Seagen Inc.
Fate Therapeutics
Coherus Oncology, Inc.
iOMEDICO AG
Summit Therapeutics